STEERlife, a leading provider of cutting-edge technologies in drug development, and Callidus Research Laboratories, a renowned pharmaceutical drug formulation expert, have joined forces in a strategic collaboration to revolutionize the process of drug development on a global scale. This partnership aims to combine STEERlife’s advanced hot melt extrusion and continuous processing technologies with Callidus’ extensive experience in pharmaceutical drug formulation.
By pooling their expertise and resources, STEERlife and Callidus are committed to pushing the boundaries of innovation in drug development. The joint efforts of these two industry giants hold the promise of delivering groundbreaking drug solutions and enhanced offerings to the market. This collaboration will also facilitate the comprehensive development of active pharmaceutical ingredients, leading to improved patient outcomes and addressing unmet medical needs.
The partnership between STEERlife and Callidus represents a significant step forward in the field of pharmaceutical research and development. By leveraging the strengths of both companies, this collaboration is poised to drive meaningful advancements in the way drugs are formulated, manufactured, and delivered to patients around the world.
In an industry where innovation is key to success, partnerships like the one between STEERlife and Callidus are essential for driving progress and meeting the evolving needs of patients and healthcare providers. By combining their respective strengths and capabilities, these two companies are well-positioned to make a significant impact on the future of drug development and ultimately improve the lives of patients.
Through their collaboration, STEERlife and Callidus are not only revolutionizing the way drugs are developed but also setting new standards for excellence in the pharmaceutical industry. With a shared commitment to innovation and patient care, these two companies are paving the way for a brighter future in healthcare and drug development.
